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ORIGINAL ARTICLE
Background/Aims: Endoscopic papillary balloon dilation (EPBD) is a safe and effective method for the treatment
of choledocholithiasis, but previous studies have rarely reported the appropriate ballooning time (BT). We
prospectively evaluated the safety and efficacy of EPBD according to BT in patients undergoing bile duct stone
removal.  
Methods: Seventy consecutive patients with bile duct stones were randomly assigned to receive EPBD with
either conventional (n = 35, 60 seconds) or short (n = 35, 20 seconds) BT.  
Results: EPBD alone achieved complete bile duct clearance in 67 patients (long BT, n = 33, 94.3%; short BT, n
= 34, 97.1%; p = 0.808). We also found no significant difference in the rate of complete duct clearance, including
procedures that used mechanical lithotripsy, between the long and short BT groups (97.1% vs. 100%; p = 0.811).
Mild pancreatitis was noted in four (11.4%) patients in the long BT group and two (5.7%) patients in the short BT
group, but this incidence was not significantly different. 
Conclusions: The study showed that EPBD using both 20-sec and 60-sec BTs is safe and effective for the
treatment of bile duct stones. Short and long BTs produced comparable outcomes. (Korean J Intern Med
2010;25:239-245)
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INTRODUCTION
Endoscopic papillary balloon dilatation (EPBD) has been
suggested as an alternative to endoscopic sphincterotomy
(EST) for the treatment of choledocholithiasis [1,2],
despite its possible association with an unacceptably high
risk of pancreatitis [3]. Because this technique dilates the
biliary sphincter without requiring surgical incision, acute
complications such as hemorrhage and perforation are
less likely [2,4,5] and biliary sphincter function is
preserved [6-8]. Despite the frequent use of EPBD, studies
have rarely reported the appropriate ballooning time (BT).
A single recent EPBD study demonstrated a decreased
tendency for post-procedural pancreatitis with a short BT
(vs. long BT), with no differences in the efficacy of bile
duct stone extraction [9]. Because patients experience
pain during an EPBD despite adequate pre-procedural
medication, the reduction in BT is desirable if the outcome
is not affected. We therefore evaluated the safety and
efficacy of EPBD performed with short and long BTs.
METHODS
Patients and study design
From September 2005 to July 2007, 70 consecutive
patients who had been diagnosed with common bile duct
(CBD) stones were randomly allocated to a long or shortBT group. Patients were excluded if they had a history of
previous EST or EPBD, choledochoduodenal fistula,
benign bile duct stricture, previous precut papillotomy, or
concomitant pancreatic or biliary malignancies. This
study was approved by the institutional review board of
our institution, and all patients provided written informed
consent before enrolling in the study.
The initial diagnostic endoscopic retrograde cholan-
giopancreatography (ERCP) provided measurements
of the CBD diameter, number of stones, and maximal
transverse diameter of the largest stone. The technical
success of the EPBD procedure was defined as the complete
removal of all CBD stones, with or without the use of
mechanical lithotripsy. Physical examination, abdominal
radiography, and measurement of serum amylase and
lipase, total bilirubin, alkaline phosphatase, and complete
blood counts were performed the morning after the ERCP
to detect early complications such as acute pancreatitis,
acute cholangitis, perforation, or bleeding. Major com-
plications associated with the ERCP were diagnosed and
their severity was graded according to modified Cotton’s
criteria [10]. Bleeding that was controlled during the
procedure without clinical evidence was not considered a
complication. Post-procedural pancreatitis was defined as
epigastric pain persisting for at least 24 hours with a serum
amylase level exceeding three times the normal level. The
pancreatitis was considered mild if hospitalization was
extended for 2 to 3 days, moderate if hospitalization lasted
4 to 10 days, and severe when hospitalization time was
prolonged for more than 10 days. Post-procedural hyper-
amylasemia was defined as a serum amylase concentration
that exceeded three times the upper limit of normal levels.
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Figure 1. Cholangiogram showing endoscopic papillary balloon dilation. (A) The biliary sphincter is visible as a ‘waist’ during balloon
inflation. (B) The biliary sphincter is adequately dilated when the balloon’s waist has completely disappeared.
A BEndoscopic procedure
The ERCP was performed with a side-viewing duo-
denoscope (TJF-240, Olympus Optical Corp. Ltd., Tokyo,
Japan) under sedation with 3 to 5 mg midazolam and
25 mg meperidine hydrochloride. Duodenal peristalsis
was suppressed with 20 mg scopolamine butylbromide.
After selective cannulation of the CBD with a 0.035-inch
cholangiography catheter (ERCP-Katheter, MTW®
Endoskopie, Wesel, Germany), an initial cholangiogram
was performed and the maximal transverse diameter
of the CBD and the largest stone was measured. The
measurements were corrected for magnification effects
using the external diameter of the distal end of the duo-
denoscope as a reference. The catheter was then removed
while the guide wire was left in place, and a balloon-tipped
catheter (CRE balloon®, Boston Scientific Corp., Natick,
MA, USA) was passed over the guide wire and placed
across the papilla. Under endoscopic and fluoroscopic
control, the balloon was gradually inflated with diluted
radiopaque contrast medium to the target diameter using
an inflation device (Indeflator®, Abbott, Santa Clara, CA,
USA). The target diameter was based on the CBD and
stone diameters.
We defined BT as the period between attainment of the
target diameter (Fig. 1) and deflation of the balloon. Short
BT in this study was 20 seconds in duration, and long BT
was 60 seconds. After dilation of the papilla, the balloon
was deflated and the balloon catheter and guide wire were
removed. CBD stones were removed with Dormia baskets
(Web® extraction basket, Wilson-Cook Medical Inc.,
Winston-Salem, NC, USA) and/or retrieval balloon
catheters (two-lumen retrieval balloon catheter, Boston
Scientific Corp.). Mechanical lithotripsy was performed
when the stone extraction could not be achieved with EPBD
alone. A balloon-occlusion cholangiogram was obtained
at the end of the procedure to ensure complete stone
removal. 
Statistical analysis
All continuous variables are expressed as means ±
standard deviation (SD). Student’s t test was used to
compare mean values between the two groups. Categorical
and binary variables were analyzed using chi-square tests.
A p value of less than 0.05 was considered statistically
significant. All analyses were performed using SPSS
version 12.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The conventional, long BT group included 35 patients
(19 men, 16 women; mean age, 66.2 ± 17.4 years), as did
the short BT group (16 men, 19 women; mean age, 63.3 ±
13.6 years). No significant differences were found in bile
duct diameter, stone number or size, or previous chole-
cystectomy between groups (Table 1). The EPBDs of three
patients (8.5%) in each group used a large (> 15 mm
diameter) balloon catheter.
EPBD achieved complete duct clearance in 33 patients
(94.3%) in the long BT group and 34 patients (97.1%) in
the short BT group; this difference was not significant (p=
0.808). All CBD stones were completely retrieved during
the initial EPBD in 32 patients (91.4%) in the long BT
group and 31 patients (88.6%) in the short BT group (p =
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Table 1. Patient demographics and procedural findings
Long BT group Short BT group p value
(n = 35) (n = 35)
Sex (M/F) 19/16 16/19 0.473
Age, yr 66.2 ± 17.4 63.3 ± 13.6 0.443
Stone number
Single 16 (45.7) 21 (60.0) 0.231
2 to 4 8 (22.9) 7 (20.0) 0.771
Over 5 11 (31.4) 7 (20.0) 0.243
Maximum stone size, mm 8.1 ± 3.5 8.2 ± 3.3 0.969
CBD diameter, mm 12.3 ± 3.1 13.1 ± 4.2 0.369
Balloon diameter, mm 9.7 ± 2.6 9.6 ± 2.4 0.904
Prior cholecystectomy 5 (14.2) 6 (17.1) 0.743
Values are presented as number (%) or  mean ± SD.
BT, ballooning time; CBD, common bile duct.0.478). Complete stone removal was achieved during the
second EPBD in one patient (2.9%) in the long BT group
and two patients (5.7%) in the short BT group (p = 0.174).
The mean numbers of sessions required for complete duct
clearance were 1.2 and 1.1, respectively, for the long and
short BT groups. No significant difference was observed in
the rate of complete bile duct clearance between groups,
independent of the use of mechanical lithotripsy (long BT,
97.1% vs. short BT, 100%; p = 0.811). One patient (2.9%)
in each group required mechanical lithotripsy (Table 2);
in these cases, the dilated biliary outlet was unexpectedly
smaller than the largest stone after EPBD, preventing
extraction. The stone of one patient in the long BT group
could not be extracted because it was impacted in the CBD
lumen, and the basket could not open properly. This stone
was extracted using peroral transpapillary cholangioscopy
with electrohydraulic lithotripsy.
Pancreatitis was noted in four patients (11.4%) in the
long BT group and two patients (5.7%) in the short BT
group (p = 0.393). All post-ERCP pancreatitis observed in
this study was mild and resolved without complications.
Asymptomatic hyperamylasemia was present in four
patients (11.4%) in the long BT group and three patients
(8.6%) in the short BT group (p = 0.690). No other
complications, such as hemorrhage, perforation, or
cholangitis, occurred in either group. Serum amylase
levels measured the morning after ERCP were 346.8 ±
55.6 IU/L in the long BT group and 198.2 ± 39.5 IU/L in
the short BT group; this difference was significant (p =
0.037) (Table 3).
DISCUSSION
EPBD is technically easy and can be readily performed
by endoscopists trained in standard therapeutic ERCP
techniques [11]. Concerns regarding the increased incidence
of ascending cholangitis and the possible recurrence of
bile duct stones after EST [12,13], especially in younger
patients, have led to the revival of EPBD. However, no
agreement has been reached on the appropriate BT, which
has been determined primarily by the operator’s experience
with the procedure. Balloon dilation has been used on the
strictures of the esophagus, pylorus, and colon. BT must
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Table 2. Efficacy of stone extraction after endoscopic papillary balloon dilation
Long BT group Short BT group p value
(n = 35) (n = 35)
Complete duct clearance with/without mechanical lithotripsy 34 (97.1) 35 (100.0) 0.811
Complete duct clearance by EPBD 33 (94.3) 34 (97.1) 0.808
Sessions required for complete duct clearance by EPBD 
1 32 (91.4) 31 (88.6) 0.478
2 1 (2.9) 3 (8.6) 0.174
Procedures including mechanical lithotripsy 1 (2.9) 1 (2.9) 1.000
Values are presented as number (%).
BT, ballooning time; EPBD, endoscopic papillary balloon dilation.
Table 3. Early complications after endoscopic papillary balloon dilation
Long BT group Short BT group p value
(n = 35) (n = 35)
Pancreatitis 4 (11.4) 2 (5.7) 0.393
Cholangitis 0 (0.0) 0 (0.0) NA
Perforation 0 (0.0) 0 (0.0) NA
Hemorrhage 0 (0.0) 0 (0.0) NA
Hyperamylasemia    4 (11.4) 3 (8.6) 0.690
Serum amylase, IU/L  346.8 ± 55.6 198.2 ± 39.5 0.037
Values are presented as number (%) or  mean ± SD.
BT, ballooning time; NA, not available.be sufficient for the dilation of the stricture and the reduction
of restenosis risk. However, the papilla is a physiologically
narrow area and should lack fibrosis unless a benign or
malignant biliary stricture is also present. Reduction in BT
may therefore help to preserve the physiological function
of the papilla after EPBD, and may also reduce the risk of
post-ERCP pancreatitis by curtailing the obstruction time
of the pancreatic duct orifice. The sphincter is thought
to be adequately dilated when the waist of the balloon
disappears completely. In our experience, the waist
disappeared within 20 seconds of achieving the target
diameter in most EPBD procedures. We therefore found it
reasonable to determine the effective minimum BT as the
time required for the waist to disappear (20 seconds), and
further believed that this minimum BT would be sufficient
to dilate the papilla.
Patients may experience abdominal pain during EPBD,
and the procedure has been associated with an increased
risk of pancreatitis. Longer BTs further exacerbate these
disadvantages [14]; BT reduction may conversely help
alleviate these problems. Previous studies have reported
BTs ranging from 30 to 120 seconds, with most operators
using a 60-second BT [11,15-20]. The present study found
comparable outcomes in the short and long BT groups,
measured by the overall technical success of stone removal.
Our results suggest that BT may be reduced when EPBD is
performed.
This study found lower rates of post-procedural pan-
creatitis and hyperamylasemia in the short BT group than
in the long BT group, but these differences were not
significant. Post-procedural serum amylase levels were
significantly lower in the short BT group than in the long
BT group. The compression of the papilla or the
pancreatic duct orifice by ballooning may cause papillary
edema or a sphincter of Oddi spasm during the EPBD
procedure, which obstructs the flow of pancreatic juice
and eventually results in a pancreatic insult [21-23].
Many factors may act independently or in concert to
cause post-ERCP pancreatitis [24-26]; high-risk
predictors include suspected sphincter of Oddi
dysfunction (SOD), young age, history of post-ERCP
pancreatitis, number of contrast injections into the
pancreatic duct, and experience of the endoscopist. This
study did not assess risk factors for post-ERCP
pancreatitis, but our data suggest that a shorter BT may
reduce the frequency of pancreatic insults during an
EPBD, thus leading to a lower incidence of pancreatitis. A
review of eight EPBD studies in which BT was specified
(Table 4) found that BT ranged from 30 to 120 seconds,
based on the operator’s personal experience, and that a
single EPBD was performed in most cases [11,15-20]. Two
or three EPBDs were performed in two studies [17,20]. A
comparison of efficacy and early complications according
to BT showed no significant differences in the results of
previous studies. Several confounding variables, however,
prevented us from ruling out the possibility of correlations.
These variables included the endoscopist’s experience and
the number of pancreatic duct cannulations. 
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Table 4. Safety and efficacy of bile duct stone extraction of previously reported endoscopic papillary balloon
dilation according to ballooning time 
Natsui Seo  [15] Vlavianos  Ochi Watanabe Bergman  Mac  Mathuna
et al. [11] et al. [16] et al. [17] et al. [18] et al. [19] et al. [20]
Number 70 42 103 55 90 101 100
BT, sec 120 60-120 30 60 × 3 120 45-60 45-60 × 2
Balloon size, mm 8 NA 10 8 8 8 < 8
Overall complications 6 (8.6) 6 (14.3) 7 (6.8) 2 (3.6) 12 (13.3) 17 (16.8) 5 (5.0)
Pancreatitis 4 (5.7) 3 (7.1) 5 (4.9) 2 (3.6) 9 (10.0) 7 (7.0) 5 (5.0) 
Cholangitis 2 (2.9) 3 (7.1) 2 (1.9) 0 (0.0) 3 (3.3) 4 (4) 0 (0.0)
Bleeding 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Overall success 65 (92.9) 34 (80.9) 90 (87) 51 (92.7) 78 (86) 90 (89) 82 (82.0)
No. of session NA 1.5 NA NA 1.6 NA NA
First session 41 (58.7) NA 65 (63) 40 (78.4) 65 (72) 81 (80) 78 (78)
Second session or more NA NA NA NA 13 (14.5) NA 4 (4)
ML or ESWL 29 (41.4) 19 (45.2) 7 (6.8) 7 (13.7) 76 (84) 31 (31) 16 (16)
Values are presented as number (%). 
BT, ballooning time; NA, not available; ML, mechanical lithotripsy; ESWL, extracorporeal shock wave lithotripsy.Tsujino et al. [27] reported immediate and long-term
complications associated with EPBD in 1000 patients;
they initially inflated the balloon with air or diluted
contrast material for 2 minutes, but reduced BT after one
patient developed severe post-procedural pancreatitis. In
the modified procedure, the balloon was inflated slowly
for 1 to 2 minutes with diluted contrast, until the waist
disappeared. The pressure was maintained for 15 seconds
and they achieved complete removal of CBD stones with
EPBD. The results of this study suggested that a short BT
was sufficient for the removal of CBD stones, and that the
ballooning speed may have been an important factor
associated with complications; a slowly inflated balloon
appeared to be less harmful to the ampulla of Vater, as it
decreased post-procedural complications.
In conclusion, this study found that EPBD with a short,
20-second BT was safe and effective. The outcomes of
procedures using a short BT were comparable to those
using a conventional, 60-second BT for the treatment of
bile duct stones. In addition, a short BT tended to be
associated with a decreased incidence of post-ERCP
pancreatitis and hyperamylasemia. Large prospective
population studies are required to confirm the safety and
efficacy of EPBD with a short BT, and to empirically define
the appropriate BT for EPBD.
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